Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer. (2017)
Attributed to:
IMPROVING RADIOIODINE TREATMENT OF THYROID AND OTHER TUMOURS
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/onc.2017.154
PubMed Identifier: 28504713
Publication URI: http://europepmc.org/abstract/MED/28504713
Type: Journal Article/Review
Volume: 36
Parent Publication: Oncogene
Issue: 37
ISSN: 0950-9232